Europe - EBR:NYXH - BE0974358906 - Common Stock
The current stock price of NYXH.BR is 4.34 EUR. In the past month the price decreased by -22.78%. In the past year, price decreased by -50.46%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 16.28 | 100.05B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 18.55 | 49.80B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.88 | 23.41B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.96 | 23.51B | ||
| BIM.PA | BIOMERIEUX | 27.72 | 12.66B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 24.57 | 3.76B | ||
| DIA.MI | DIASORIN SPA | 17.18 | 3.34B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.36 | 1.25B | ||
| DRW8.DE | DRAEGERWERK AG | 9.12 | 1.10B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 26.92 | 1.01B | ||
| ELN.MI | EL.EN. SPA | 16.95 | 870.50M | ||
| GVS.MI | GVS SPA | 46.44 | 790.77M |
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 184 full-time employees. The company went IPO on 2020-09-18. The firm focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
NYXOAH SA
Rue Edouard Belin 12
Mont-Saint-Guibert BRABANT-WALLON BE
Employees: 184
Phone: 3226121755
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 184 full-time employees. The company went IPO on 2020-09-18. The firm focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
The current stock price of NYXH.BR is 4.34 EUR. The price increased by 0.23% in the last trading session.
NYXH.BR does not pay a dividend.
NYXH.BR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
NYXOAH SA (NYXH.BR) currently has 184 employees.
NYXOAH SA (NYXH.BR) has a market capitalization of 162.45M EUR. This makes NYXH.BR a Micro Cap stock.
NYXOAH SA (NYXH.BR) will report earnings on 2025-11-13.
ChartMill assigns a fundamental rating of 3 / 10 to NYXH.BR. While NYXH.BR seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months NYXH.BR reported a non-GAAP Earnings per Share(EPS) of -2.11. The EPS decreased by -41.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -66.28% | ||
| ROE | -105.18% | ||
| Debt/Equity | 0.29 |
14 analysts have analysed NYXH.BR and the average price target is 12.19 EUR. This implies a price increase of 180.85% is expected in the next year compared to the current price of 4.34.
For the next year, analysts expect an EPS growth of -18.11% and a revenue growth 57.01% for NYXH.BR